If you have questions, please call us for more information about clinical trials or use our online form.
- Cancer clinical trials: 414-805-8900
- Noncancer clinical trials: 414-955-8555
Learn more about clinical trials basics and early-phase clinical trials, as well as some of the unique features our research program, including our Translational Research Unit. Froedtert & MCW health network is also part of the National Institutes of Health All of Us Research Program.
Displaying 1 - 3 of 3
A Randomized, Double-blind, Placebo-controlled Multicenter Study to Assess the Efficacy and Safety of Lenrispodun as Adjunctive Therapy in the Treatment of Patients with Motor Fluctuations due to Parkinson's Disease
Objective
Lenrispodun Adjunctive Therapy in Parkinsons Disease
Protocol No
NEURO-ITI-214-202-LENRISPODUN
Parkinson's Foundation PD GENEration Genetic Registry
Objective
Parkinson's Foundation PD GENEration Genetic Registry
Protocol No
NEURO-PF-PDGENE
A Multicenter, Randomized, Double-Blind, Sham-Controlled Study Assessing the Efficacy and Safety of iovera system in Subjects with Upper Extremity Spasticity
Objective
Iovera in Upper Extremity Spasticity
Protocol No
PMR-PACIRA-IOV-301